1b9w: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1b9w.jpg|left|200px]] | [[Image:1b9w.jpg|left|200px]] | ||
'''C-TERMINAL MEROZOITE SURFACE PROTEIN 1 FROM PLASMODIUM CYNOMOLGI''' | {{Structure | ||
|PDB= 1b9w |SIZE=350|CAPTION= <scene name='initialview01'>1b9w</scene>, resolution 1.800Å | |||
|SITE= | |||
|LIGAND= | |||
|ACTIVITY= | |||
|GENE= | |||
}} | |||
'''C-TERMINAL MEROZOITE SURFACE PROTEIN 1 FROM PLASMODIUM CYNOMOLGI''' | |||
==Overview== | ==Overview== | ||
| Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
1B9W is a [ | 1B9W is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Plasmodium_cynomolgi Plasmodium cynomolgi]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1B9W OCA]. | ||
==Reference== | ==Reference== | ||
The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate., Chitarra V, Holm I, Bentley GA, Petres S, Longacre S, Mol Cell. 1999 Apr;3(4):457-64. PMID:[http:// | The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate., Chitarra V, Holm I, Bentley GA, Petres S, Longacre S, Mol Cell. 1999 Apr;3(4):457-64. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10230398 10230398] | ||
[[Category: Plasmodium cynomolgi]] | [[Category: Plasmodium cynomolgi]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| Line 21: | Line 30: | ||
[[Category: surface antigen]] | [[Category: surface antigen]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 10:08:13 2008'' | ||
Revision as of 08:08, 20 March 2008
| |||||||||||||
| 1b9w, resolution 1.800Å | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coordinates: | save as pdb, mmCIF, xml | ||||||||||||
C-TERMINAL MEROZOITE SURFACE PROTEIN 1 FROM PLASMODIUM CYNOMOLGI
Overview
The C-terminal proteolytic processing product of merozoite surface protein 1 (MSP1) appears essential for successful erythrocyte invasion by the malarial parasite, Plasmodium. We have determined the crystal structure at 1.8 A resolution of a soluble baculovirus-recombinant form of the protein from P. cynomolgi, which confers excellent protective efficacy in primate vaccination trials. The structure comprises two EGF-like domains, and sequence comparisons strongly suggest that the same conformation is present in all species of Plasmodium, including P. falciparum and P. vivax, which are pathogenic in man. In particular, conserved interdomain contacts between the two EGF modules should preserve the compact form of the molecule in all species. Implications of the crystal structure for anti-malarial vaccine development are discussed.
About this Structure
1B9W is a Single protein structure of sequence from Plasmodium cynomolgi. Full crystallographic information is available from OCA.
Reference
The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate., Chitarra V, Holm I, Bentley GA, Petres S, Longacre S, Mol Cell. 1999 Apr;3(4):457-64. PMID:10230398
Page seeded by OCA on Thu Mar 20 10:08:13 2008
